Noninvasive Lower-Airway Antibody Measurement May Advance Mucosal Vaccine Development
-
By
-
Debbie Bunch
-
November 16, 2026
By
Debbie Bunch
November 16, 2026
by Debbie Bunch
November 16, 2026
Longer disease control without a statistically significant survival benefit did not support approval.
by Mouj Hijazi
November 16, 2026
by Debbie Bunch
November 16, 2026
New guidance addresses COVID-19, influenza, and RSV across age and risk groups.
by Teraya Smith
November 6, 2026